Cancer gene therapy /

Saved in:
Bibliographic Details
Imprint:Totowa, N.J. : Humana Press, c2005.
Description:xii, 489 p. : ill. ; 26 cm.
Language:English
Series:Contemporary cancer research
Subject:
Format: Print Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/5528903
Hidden Bibliographic Details
Other authors / contributors:Curiel, David.
Douglas, Joanne T.
ISBN:1588292134 (alk. paper)
1592597858 (e-isbn)
Notes:Includes bibliographical references and index.

MARC

LEADER 00000nam a22000004a 4500
001 5528903
003 ICU
005 20050810123300.0
008 040508s2005 njua b 001 0 eng
010 |a  2004010875 
016 7 |a 101216499  |2 DNLM 
020 |a 1588292134 (alk. paper) 
020 |a 1592597858 (e-isbn) 
040 |a DNLM/DLC  |c DLC  |d YDX  |d NLM  |d CGU  |d UtOrBLW  |d OrLoB-B 
042 |a pcc 
049 |a CGUA 
050 0 0 |a RC271.G45  |b C355 2005 
060 0 0 |a 2004 L-762 
060 1 0 |a QZ 266  |b C21433 2005 
082 0 0 |a 616.99/40694  |2 22 
245 0 0 |a Cancer gene therapy /  |c edited by David T. Curiel, Joanne T. Douglas. 
260 |a Totowa, N.J. :  |b Humana Press,  |c c2005. 
300 |a xii, 489 p. :  |b ill. ;  |c 26 cm. 
336 |a text  |b txt  |2 rdacontent  |0 http://id.loc.gov/vocabulary/contentTypes/txt 
337 |a unmediated  |b n  |2 rdamedia  |0 http://id.loc.gov/vocabulary/mediaTypes/n 
338 |a volume  |b nc  |2 rdacarrier  |0 http://id.loc.gov/vocabulary/carriers/nc 
440 0 |a Contemporary cancer research 
504 |a Includes bibliographical references and index. 
505 0 0 |g 1.  |t Cancer gene therapy : historical perspective /  |r Malcolm K. Brenner --  |g 2.  |t The genetic basis of cancer /  |r Akseli Hemminki and Kari Hemminki --  |g 3.  |t Tumor suppressor gene replacement for cancer /  |r Jack A. Roth and Susan F. Grammer --  |g 4.  |t Antisense technology /  |r Ruiwen Zhang and Hui Wang --  |g 5.  |t Cancer therapeutic applications of ribozymes and RNAi /  |r Lisa Scherer and John J. Rossi --  |g 6.  |t Fusogeneic membrane glycoproteins for cancer gene therapy : a better class of killer /  |r Andrew Bateman, Vy Phan, Alan Melcher, Emmanouela Linardakis, Kevin Harrington and Richard Vile --  |g 7.  |t Suicide gene therapy /  |r Caroline J. Springer and Ion Niculescu-Duvaz --  |g 8.  |t Molecular chemotherapy approaches /  |r Daniel H. Palmer and David J. Kerr --  |g 9.  |t Genetic immunotherapy approaches /  |r Denise R. Shaw and Albert F. LoBuglio --  |g 10.  |t Immunotherapy of cancer by dendritic cell-targeted gene transfer /  |r Tanja D. de Gruijl, Herbert M. Pinedo and Rik J. Scheper --  |g 11.  |t Dendritic cells /  |r Weiping Zou, Shuang Wei and Tyler J. Curiel --  |g 12.  |t Polynucleotide immunization for cancer therapy /  |r Theresa V. Strong --  |g 13.  |t Development of oncolytic replication-competent herpes simplex virus vectors : the G207 paradigm /  |r Tomoki Todo and Samuel D. Rabkin --  |g 14.  |t Development of oncolytic adenoviruses : from the lab bench to the bedside /  |r John A. Howe, Robert Ralston and Murali Ramachandra --  |g 15.  |t Conditionally replicating adenoviruses for cancer treatment /  |r Ramon Alemany --  |g 16.  |t Reovirus as an oncolytic agent /  |r Megan K. Patrick, Kara L. Norman and Patrick W. K. Lee --  |g 17.  |t Antiangiogenic gene therapy of cancer /  |r Steve Gyorffy, Jack Gauldie, A. Keith Stewart and Xiao-Yan Wen --  |g 18.  |t Proapoptotic strategy in cancer gene therapy /  |r David H. Holman, Marc L. Hyer, Ahmed El-Zawahry, Gina M. Keller and James S. Norris --  |g 19.  |t Antimetastasis /  |r Duen-Hwa Yan, Kung-Ming Rau and Mien-Chie Hung --  |g 20.  |t Antimetastatic gene therapy : prostate cancer theory to therapy /  |r Thomas A. Gardner, Juan Antonio Jimenez, Leland W. K. Chung and Chinghai Kao --  |g 21.  |t Drug resistance gene transfer as an antitumor strategy /  |r Colin L. Sweeney and R. Scott McIvor --  |g 22.  |t Chemosensitization /  |r Per Eystein Lonning --  |g 23.  |t Radiosensitizaton by gene theraphy /  |r Steven J. Chmura, Michael Garofalo and Ralph R. Weichselbaum --  |g 24.  |t Nonviral vector systems for cancer gene therapy /  |r Greg F. Walker and Ernst Wagner --  |g 25.  |t Viral vectors for cancer gene therapy /  |r Joanne T. Douglas and David T. Curiel --  |g 26.  |t Bacterial systems for tumor-specific gene therapy /  |r J. Martin Brown, Shie-Chau Liu, Jan Theys and Philippe Lambin --  |g 27.  |t Molecular imaging of cancer gene therapy /  |r Harvey R. Herschman --  |g 28.  |t Cancer-related gene therapy clinical trials /  |r Robert J. Korst and Ronald G. Crystal --  |g 29.  |t Regulatory aspects in the development of gene therapies /  |r Rosemarie Aurigemma, Joseph E. Tomaszewski, Sheryl Ruppel, Stephen Creekmore and Edward A. Sausville. 
650 0 |a Cancer  |x Gene therapy.  |0 http://id.loc.gov/authorities/subjects/sh92005201 
650 1 2 |a Gene Therapy. 
650 1 2 |a Neoplasms  |x therapy. 
650 7 |a Cancer  |x Gene therapy.  |2 fast  |0 http://id.worldcat.org/fast/fst00845367 
700 1 |a Curiel, David.  |0 http://id.loc.gov/authorities/names/n97802979  |1 http://viaf.org/viaf/21434052 
700 1 |a Douglas, Joanne T.  |0 http://id.loc.gov/authorities/names/n2002013502  |1 http://viaf.org/viaf/48582102 
901 |a ToCBNA 
903 |a HeVa 
035 |a (OCoLC)55138530 
929 |a cat 
999 f f |i 0231e761-7ac5-5afa-8f0d-3910d7d365e8  |s 4d8d94be-c96f-5d8b-8057-da1814c9fcde 
928 |t Library of Congress classification  |a RC271.G45C355 2005  |l JCL  |c JCL-Sci  |i 6497726 
927 |t Library of Congress classification  |a RC271.G45C355 2005  |l JCL  |c JCL-Sci  |e CRERAR  |b 64567015  |i 7778462